Larson Financial Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Other funds holding MCRB
Larson Financial Group's MCRB Position: Q3 2026 in Review
Larson Financial Group held its Seres Therapeutics (MCRB) position steady in Q3 2026 at 5 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #3823.
Larson Financial Group first reported a position in MCRB in Q3 2022 and has held it in 12 quarters since. The position peaked at $2K in Q3 2022. 40 funds tracked by Wall St. Rank hold MCRB as of Q3 2026.
- Larson Financial Group held 5 shares of Seres Therapeutics worth $17 as of Q3 2026.
- Larson Financial Group left its Seres Therapeutics share count unchanged in Q3 2026.
- Seres Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3823 holding.
- Larson Financial Group first reported a position in Seres Therapeutics in Q3 2022 and has held it in 12 quarters since.
- Larson Financial Group's Seres Therapeutics position peaked at $2K in Q3 2022.
- 40 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.